Clinical Trial Update: Safety Study of Homeo-GH (Bone Marrow Derived Clonal Mesenchymal Stem Cell) to Treat Acute/Chronic Graft Versus Host Disease (GVHD) [Phase 1]

View source ↗

Summary

Phase 1 safety study of Homeo-GH, a bone marrow–derived clonal mesenchymal stem cell therapy, for acute and chronic graft-versus-host disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Homeo-GH

Snippet

Sponsor: HomeoTherapy Co., Ltd | Conditions: Graft-vs-Host Disease | Phase 1 | Status: COMPLETED